Divi's Laboratories Executive and Leadership Team

Kiran Divi, the Chief Executive Officer at Divi's Laboratories, directs the overarching corporate strategy and long-term growth initiatives for the organization. By overseeing the production of generic APIs and complex intermediates, the Chief Executive Officer ensures that manufacturing processes meet stringent global quality benchmarks. Kiran Divi maintains constant alignment with the Board to drive expansion across international pharmaceutical markets. This leadership role involves optimizing supply chain efficiency and fostering innovation within the nutraceutical ingredients division. Through the implementation of advanced synthesis technologies, the Chief Executive Officer secures a competitive advantage in the global landscape. By prioritizing operational excellence and sustainable growth, the Chief Executive Officer strengthens the market position of the company. Ultimately, Divi drives the strategic vision required to maintain leadership in the pharmaceutical manufacturing sector.

Kishorebabu Lingamneni, the Chief Financial Officer at Divi's Laboratories, directs the financial planning, capital allocation, and fiscal reporting for the organization. Overseeing the management of global revenue streams and cost structures, the Chief Financial Officer ensures the financial health required to support large-scale pharmaceutical manufacturing. Kishorebabu Lingamneni maintains rigorous oversight of budgetary compliance and investment strategies to facilitate expansion into new international markets. This leadership role involves providing the Board with detailed financial analysis to guide strategic decision-making regarding capital expenditures and resource distribution. By optimizing financial performance, the Chief Financial Officer supports the long-term sustainability of the company. The Chief Financial Officer manages risk assessment and fiscal transparency to uphold investor confidence. Ultimately, Lingamneni secures the financial stability necessary for the continued development of generic APIs and nutraceutical ingredients.

Manoranjan Jasti, the Chief Information Officer at Divi's Laboratories, directs the digital transformation and technological infrastructure necessary for modern pharmaceutical manufacturing. Overseeing the integration of data analytics and secure information systems, the Chief Information Officer ensures that manufacturing data remains accurate and accessible for global operations. Manoranjan Jasti architects robust cybersecurity protocols to protect proprietary synthesis processes and intellectual property. This leadership role involves collaborating with production teams to implement automated systems that enhance manufacturing efficiency and quality control. By modernizing the digital landscape, the Chief Information Officer supports the company in maintaining a competitive edge within the pharmaceutical sector. The Chief Information Officer drives the adoption of advanced software solutions to streamline internal workflows and improve cross-departmental communication. Ultimately, Jasti ensures that technological capabilities align with the strategic goals of the organization.

Murali Divi, the Managing Director at Divi's Laboratories, oversees the foundational operational framework and technical development of the company. As the Managing Director, Murali Divi architects the research and development initiatives that define the production of custom synthesized APIs. This role involves managing large-scale manufacturing facilities and ensuring compliance with international regulatory standards across all regional operations. By coordinating with technical teams, the Managing Director facilitates the transition of complex chemical processes from laboratory scale to commercial production. The Managing Director maintains a focus on scientific integrity and process optimization to support the broader corporate mission. Through the application of deep industry expertise, the Managing Director ensures that manufacturing capabilities remain at the forefront of the pharmaceutical industry. This leadership position directly impacts the scalability and reliability of the entire product portfolio.